Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 731,000 | 5.9M | 9.7M |
| Operating Revenue | 0.00 | 731,000 | 5.9M | 9.7M |
| Cost Of Revenue | 292,000 | 406,000 | 5.4M | 14.4M |
| Gross Profit | -292,000 | 325,000 | 474,000 | -4.7M |
| Selling General And Administration | 3.3M | 2.4M | 5.0M | 2.0M |
| General And Administrative Expense | 3.3M | 2.4M | 5.0M | 2.0M |
| Other Operating Expenses | 5.5M | 4.0M | 8.3M | 4.6M |
| Operating Expense | 9.1M | 6.6M | 13.9M | 6.5M |
| Operating Income | -9.4M | -6.3M | -13.5M | -11.2M |
| EBIT | -9.4M | -2.0M | -11.4M | -11.2M |
| Interest Expense | -- | 5,000 | 8,000 | -- |
| Interest Expense Non Operating | -- | 5,000 | 8,000 | -- |
| Interest Income | 22,000 | -- | -- | 3,000 |
| Interest Income Non Operating | 22,000 | -- | -- | 3,000 |
| Net Interest Income | 22,000 | -5,000 | -8,000 | 3,000 |
| Other Income Expense | 4.6M | 4.3M | 2.1M | 2.5M |
| Other Non Operating Income Expenses | 4.5M | 3.8M | 2.2M | 2.3M |
| Special Income Charges | 77,000 | 444,000 | 0.00 | 73,000 |
| Write Off | 423,000 | 481,000 | 0.00 | -- |
| Gain On Sale Of Security | -59,000 | 43,000 | -91,000 | 87,000 |
| Pretax Income | -4.8M | -2.0M | -11.4M | -8.8M |
| Tax Provision | -- | -- | 0.00 | 5,000 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 42,400 |
| Net Income From Continuing And Discontinued Operation | -4.8M | -2.0M | -11.4M | -8.8M |
| Net Income From Continuing Operation Net Minority Interest | -4.8M | -2.0M | -11.4M | -8.8M |
| Net Income Including Noncontrolling Interests | -4.8M | -2.0M | -11.4M | -8.8M |
| Net Income Common Stockholders | -4.8M | -2.0M | -11.4M | -8.8M |
| Net Income | -4.8M | -2.0M | -11.4M | -8.8M |
| EBITDA | -9.1M | -1.6M | -10.6M | -10.1M |
| Normalized EBITDA | -9.1M | -2.1M | -10.5M | -10.2M |
| Reconciled Depreciation | 292,000 | 406,000 | 820,000 | 1.2M |
| Basic EPS | -0.03 | -0.03 | -0.17 | -0.19 |
| Diluted EPS | -0.03 | -0.03 | -0.17 | -0.19 |
| Basic Average Shares | 140.4M | 70.1M | 68.2M | 47.0M |
| Diluted Average Shares | 140.4M | 70.1M | 68.2M | 47.0M |
| Total Unusual Items | 18,000 | 487,000 | -91,000 | 160,000 |
| Total Unusual Items Excluding Goodwill | 18,000 | 487,000 | -91,000 | 160,000 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.27 |
| Normalized Income | -4.8M | -2.5M | -11.3M | -8.9M |
| Diluted NI Availto Com Stockholders | -4.8M | -2.0M | -11.4M | -8.8M |
| Gain On Sale Of Ppe | 500,000 | 910,000 | 0.00 | 73,000 |
| Net Income Continuous Operations | -4.8M | -2.0M | -11.4M | -8.8M |
| Net Non Operating Interest Income Expense | 22,000 | -5,000 | -8,000 | 3,000 |
| Other Gand A | 2.0M | 1.4M | 2.2M | 2.0M |
| Other Special Charges | -- | -15,000 | -- | -- |
| Other Taxes | 230,000 | 174,000 | 649,000 | -- |
| Reconciled Cost Of Revenue | 292,000 | 406,000 | 5.4M | 14.4M |
| Salaries And Wages | 1.3M | 989,000 | 2.8M | -- |
| Total Expenses | 9.4M | 7.0M | 19.4M | 20.9M |
| Total Operating Income As Reported | -- | -6.1M | -13.3M | -11.1M |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 7.4M | 3.1M | 630,000 | 10.0M |
| Cash Cash Equivalents And Short Term Investments | 7.4M | 3.2M | 665,000 | 10.2M |
| Cash Equivalents | 35,000 | 35,000 | -- | -- |
| Cash Financial | 7.4M | 3.1M | -- | -- |
| Other Short Term Investments | 18,000 | 71,000 | 35,000 | 213,000 |
| Receivables | -- | 354,000 | 400,000 | 462,000 |
| Inventory | 0.00 | 423,000 | 905,000 | 1.2M |
| Prepaid Assets | -- | -- | 400,000 | 462,000 |
| Other Current Assets | 679,000 | 354,000 | 400,000 | 462,000 |
| Current Assets | 8.1M | 3.9M | 2.0M | 11.8M |
| Gross PPE | 75.0M | 74.8M | 75.0M | 91.5M |
| Accumulated Depreciation | -43.9M | -43.6M | -43.2M | -58.1M |
| Net PPE | 31.1M | 31.2M | 31.8M | 33.4M |
| Other Non Current Assets | 400,000 | 400,000 | 400,000 | 400,000 |
| Total Non Current Assets | 31.5M | 31.6M | 32.2M | 33.8M |
| Total Assets | 39.6M | 35.6M | 34.2M | 45.6M |
| Accounts Payable | 421,000 | 1.7M | 2.5M | 602,000 |
| Payables | 421,000 | 1.7M | 2.5M | 602,000 |
| Payables And Accrued Expenses | 896,000 | 1.9M | 2.9M | 914,000 |
| Current Accrued Expenses | 475,000 | 258,000 | 394,000 | 312,000 |
| Other Current Liabilities | 1.4M | 80,000 | -- | 1.6M |
| Current Liabilities | 2.6M | 2.3M | 3.5M | 3.2M |
| Other Non Current Liabilities | 15,000 | 2.7M | 2.5M | 3.1M |
| Total Non Current Liabilities Net Minority Interest | 2.9M | 2.7M | 2.5M | 3.1M |
| Total Liabilities Net Minority Interest | 5.5M | 5.0M | 6.0M | 6.3M |
| Common Stock | 44.2M | 36.0M | 31.8M | 31.8M |
| Capital Stock | 44.2M | 36.0M | 31.8M | 31.8M |
| Additional Paid In Capital | -- | -- | 130.1M | 130.1M |
| Retained Earnings | -141.8M | -137.0M | -135.1M | -123.7M |
| Gains Losses Not Affecting Retained Earnings | 130.1M | 130.1M | 130.1M | 0.00 |
| Other Equity Adjustments | 130.1M | 130.1M | 130.1M | -- |
| Common Stock Equity | 34.1M | 30.5M | 28.2M | 39.3M |
| Stockholders Equity | 34.1M | 30.5M | 28.2M | 39.3M |
| Total Equity Gross Minority Interest | 34.1M | 30.5M | 28.2M | 39.3M |
| Total Capitalization | 34.1M | 30.5M | 28.2M | 39.3M |
| Net Tangible Assets | 34.1M | 30.5M | 28.2M | 39.3M |
| Tangible Book Value | 34.1M | 30.5M | 28.2M | 39.3M |
| Working Capital | 5.5M | 1.6M | -1.5M | 8.6M |
| Invested Capital | 34.1M | 30.5M | 28.2M | 39.3M |
| Share Issued | 192.3M | 134.5M | 68.2M | 68.2M |
| Ordinary Shares Number | 192.3M | 134.5M | 68.2M | 68.2M |
| Buildings And Improvements | 13.5M | 13.5M | 13.6M | -- |
| Finished Goods | -- | -- | 0.00 | 74,000 |
| Long Term Provisions | 2.9M | 2.7M | 2.5M | 3.1M |
| Machinery Furniture Equipment | 124,000 | 124,000 | 124,000 | 29.4M |
| Non Current Deferred Liabilities | 15,000 | 0.00 | -- | -- |
| Other Equity Interest | 1.6M | 1.5M | 1.4M | 1.1M |
| Other Properties | 164,000 | -- | -- | -- |
| Other Receivables | -- | 354,000 | 400,000 | 462,000 |
| Pensionand Other Post Retirement Benefit Plans Current | 309,000 | 311,000 | 600,000 | 644,000 |
| Raw Materials | 0.00 | 423,000 | 905,000 | 986,000 |
| Treasury Shares Number | -- | 0.00 | -- | -- |
| Work In Process | -- | -- | 0.00 | 99,000 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -5.8M | -2.6M | -9.3M | -7.3M |
| Cash Flow From Continuing Operating Activities | -5.8M | -2.6M | -9.3M | -7.3M |
| Depreciation Amortization Depletion | 292,000 | 406,000 | 820,000 | 1.2M |
| Stock Based Compensation | 158,000 | 116,000 | 297,000 | 200,000 |
| Change In Working Capital | -1.4M | -778,000 | 2.4M | 584,000 |
| Change In Inventory | -- | 482,000 | 254,000 | 1.6M |
| Change In Payables And Accrued Expense | -1.0M | -824,000 | 2.0M | -1.1M |
| Change In Payable | -1.0M | -535,000 | 2.1M | -1.2M |
| Other Non Cash Items | -34,000 | 179,000 | -1.5M | -336,000 |
| Capital Expenditure | -114,000 | -- | -37,000 | -357,000 |
| Purchase Of PPE | -- | -- | -- | -357,000 |
| Net PPE Purchase And Sale | 450,000 | 1.2M | 0.00 | 284,000 |
| Investing Cash Flow | 336,000 | 1.2M | -37,000 | -473,000 |
| Cash Flow From Continuing Investing Activities | 336,000 | 1.2M | -37,000 | -473,000 |
| Issuance Of Capital Stock | 7.7M | 3.9M | 0.00 | 7.6M |
| Net Common Stock Issuance | 7.7M | 3.9M | 0.00 | 7.6M |
| Financing Cash Flow | 9.7M | 3.9M | 0.00 | 7.7M |
| Cash Flow From Continuing Financing Activities | 9.7M | 3.9M | 0.00 | 7.7M |
| Changes In Cash | 4.3M | 2.5M | -9.3M | -75,000 |
| Beginning Cash Position | 3.1M | 630,000 | 10.0M | 10.0M |
| End Cash Position | 7.4M | 3.1M | 630,000 | 10.0M |
| Free Cash Flow | -5.9M | -2.6M | -9.3M | -7.6M |
| Asset Impairment Charge | 423,000 | 482,000 | -- | -- |
| Capital Expenditure Reported | -114,000 | 0.00 | -37,000 | -357,000 |
| Change In Account Payable | -1.0M | -535,000 | 2.1M | -1.2M |
| Change In Accrued Expense | -2,000 | -289,000 | -44,000 | 143,000 |
| Change In Prepaid Assets | -325,000 | 46,000 | 62,000 | 44,000 |
| Common Stock Issuance | 7.7M | 3.9M | 0.00 | 7.6M |
| Gain Loss On Investment Securities | 53,000 | -51,000 | 53,000 | -88,000 |
| Gain Loss On Sale Of PPE | -500,000 | -910,000 | 0.00 | -73,000 |
| Net Foreign Currency Exchange Gain Loss | 6,000 | 0.00 | 31,000 | 1,000 |
| Net Income From Continuing Operations | -4.8M | -2.0M | -11.4M | -8.8M |
| Net Other Investing Changes | -- | -- | -37,000 | -400,000 |
| Operating Gains Losses | -441,000 | -961,000 | 84,000 | -160,000 |
| Proceeds From Stock Option Exercised | 2.0M | 0.00 | 0.00 | 90,000 |
| Sale Of PPE | 450,000 | 1.2M | 0.00 | 284,000 |